Live SpaceX Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow NextCure, Inc.

Get SEC filing alerts via email and in your feed for NextCure, Inc.

NXTC

NextCure, Inc.

About NextCure, Inc.

NextCure, Inc. is a clinical-stage biopharmaceutical company developing innovative cancer therapies, primarily antibody-drug conjugates (ADCs). Its lead candidate, LNCB74, targets B7-H4, a tumor-associated protein, for cancers like breast and ovarian. The company also explores non-oncology programs, collaborates with LigaChem and Yale, and focuses on advancing targeted biologics through research, development, and strategic partnerships.
This description was generated via AI from an annual report. Updated 9 months ago.

Latest SEC Filings from NextCure, Inc.

1
1
NextCure, Inc. NextCure Reports $9.8 Million Net Loss in Q1 2026, Highlights Clinical Advancements

Via official filing (AI summary) | about 1 month ago | 0 comments

2
1
NextCure, Inc. NextCure Reports $55.8 Million Net Loss for Fiscal Year 2025, Enters License Agreement for SIM0505

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
NextCure, Inc. NextCure Reports $8.6 Million Net Loss in Q3 2025, Plans for Capital Raise

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
NextCure, Inc. NextCure Reports $26.8 Million Net Loss and Financial Challenges in Latest 10-Q Filing

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
NextCure, Inc. NextCure Reports $10.976 Million Net Loss in Q1 2025, Focuses on LNCB74 Development

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
NextCure, Inc. NextCure Reports Decreased Net Loss and Restructuring Plan Amid Ongoing Development of LNCB74

Via official filing (AI summary) | over 1 year ago | 0 comments

7
1
NextCure, Inc. NextCure Reports Improved Financials, Reduced Losses, and Advancements in Cancer Treatment Development

Via official filing (AI summary) | over 1 year ago | 0 comments